COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 615: Articles 6141-6150  | Next

High SARS-CoV-2 seroprevalence in Lagos, Nigeria with robust antibody and cellular responses
Akanmu, S., Herrera, B. B., Chaplin, B., Ogunsola, F., Osibogun, A., Onawoga, F., John-Olabode, S., Akase, I. E., Nwosu, A., Hamel, D. J., Chang, C. A., Kanki, P. J.
10.1101/2022.11.30.22282833 — Posted: 2022-12-01
Pilot Study Demonstrates Benefits of Nursing Home Air Purification on COVID-19 Outcomes
Jutkowitz, E., Shwemaker, P., Reddy, A., Braun, J., Baier, R.
10.1101/2022.12.01.22282978 — Posted: 2022-12-01
Trends in patients' willingness for cancer care and the number of registered cancer cases in Ehime Prefecture during the COVID-19 pandemic
Teramoto, N., Yamashita, N., Ohira, Y.
10.1101/2022.11.30.22282924 — Posted: 2022-12-01
Severe acute infection and chronic pulmonary disease are risk factors for developing post-COVID-19 conditions
Ghosh, P., Niesen, M. J., Pawlowski, C., Bandi, H., Yoo, U., Lenehan, P. J., Kumar, P., Nadig, M., Ross, J., Ardhanari, S., O'Horo, J. C., Venkatakrishnan, A. J., Rosen, C. J., Telenti, A., Hurt, R., Soundararajan, V.
10.1101/2022.11.30.22282831 — Posted: 2022-12-01
SARS-CoV-2 mRNA vaccine is re-adenylated in vivo, enhancing antigen production and immune response
Krawczyk, P. S., Gewartowska, O., Mazur, M., Orzel, W., Matylla-Kulinska, K., Jelen, S., Turowski, P., Spiewla, T., Tarkowski, B., Tudek, A., Brouze, A., Wesolowska, A., Nowis, D., Golab, J., Kowalska, J., Jemielity, J., Dziembowski, A., Mroczek, S.
10.1101/2022.12.01.518149 — Posted: 2022-12-01
Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2
Becerra-Artiles, A., Nanaware, P. P., Muneeruddin, K., Weaver, G. C., Shaffer, S. A., Calvo-Calle, J. M., Stern, L. J.
10.1101/2022.12.01.518643 — Posted: 2022-12-01
Clinical, imaging, serological, and histopathological features of pulmonary post-acute sequelae after mild COVID-19 (PASC)
Gagiannis, D., Hackenbroch, C., Czech, A., Lindner, A., Maag, N., Bloch, W., Zech, F., Kirchhoff, F., Djudjaj, S., von Stillfried, S. E., Buelow, R., Boor, P., Steinestel, K.
10.1101/2022.11.29.22282913 — Posted: 2022-11-30
The imprinting effect of COVID-19 vaccines: an expected selection bias in observational studies
Monge, S., Pastor-Barriuso, R., Hernan, M. A.
10.1101/2022.11.30.22282923 — Posted: 2022-11-30
A Transformer-Based Model Trained on Large Scale Claims Data for Prediction of Severe COVID-19 Disease Progression
Lentzen, M., Linden, T., Veeranki, S., Madan, S., Kramer, D., Leodolter, W., Froehlich, H., COPERIMOplus
10.1101/2022.11.29.22282632 — Posted: 2022-11-30
Continuous Positive Airway Pressure (CPAP) in Covid 19 Acute Respiratory Distress Syndrome (ARDS): A Systematic Review
Hoole, A.
10.1101/2022.11.29.22282819 — Posted: 2022-11-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).